Number of the records: 1  

Microsecond MD Simulation and Multiple-Conformation Virtual Screening to Identify Potential Anti-COVID-19 Inhibitors Against SARS-CoV-2 Main Protease

  1. 1.
    SYSNO ASEP0539587
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleMicrosecond MD Simulation and Multiple-Conformation Virtual Screening to Identify Potential Anti-COVID-19 Inhibitors Against SARS-CoV-2 Main Protease
    Author(s) Selvaraj, C. (IN)
    Panwar, U. (IN)
    Dinesh, Dhurvas Chandrasekaran (UOCHB-X) ORCID
    Bouřa, Evžen (UOCHB-X) ORCID
    Singh, P. (IN)
    Dubey, V. K. (IN)
    Singh, S. K. (IN)
    Article number595273
    Source TitleFrontiers in Chemistry. - : Frontiers Media - ISSN 2296-2646
    Roč. 8, Jan 13 (2021)
    Number of pages15 s.
    Languageeng - English
    CountryCH - Switzerland
    KeywordsSARS-CoV-2 main protease ; COVID-19 ; TCM ; natural products ; molecular dynamics ; ensemble sampling
    OECD categoryBiochemistry and molecular biology
    R&D ProjectsEF16_019/0000729 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Method of publishingOpen access
    Institutional supportUOCHB-X - RVO:61388963
    UT WOS000612010100001
    EID SCOPUS85100261875
    DOI10.3389/fchem.2020.595273
    AnnotationThe recent pandemic outbreak of COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), raised global health and economic concerns. Phylogenetically, SARS-CoV-2 is closely related to SARS-CoV, and both encode the enzyme main protease (Mpro/3CLpro), which can be a potential target inhibiting viral replication. Through this work, we have compiled the structural aspects of Mpro conformational changes, with molecular modeling and 1-μs MD simulations. Long-scale MD simulation resolves the mechanism role of crucial amino acids involved in protein stability, followed by ensemble docking which provides potential compounds from the Traditional Chinese Medicine (TCM) database. These lead compounds directly interact with active site residues (His41, Gly143, and Cys145) of Mpro, which plays a crucial role in the enzymatic activity. Through the binding mode analysis in the S1, S1′, S2, and S4 binding subsites, screened compounds may be functional for the distortion of the oxyanion hole in the reaction mechanism, and it may lead to the inhibition of Mpro in SARS-CoV-2. The hit compounds are naturally occurring compounds, they provide a sustainable and readily available option for medical treatment in humans infected by SARS-CoV-2. Henceforth, extensive analysis through molecular modeling approaches explained that the proposed molecules might be promising SARS-CoV-2 inhibitors for the inhibition of COVID-19, subjected to experimental validation.
    WorkplaceInstitute of Organic Chemistry and Biochemistry
    Contactasep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Jana Procházková, Tel.: 220 183 418
    Year of Publishing2022
    Electronic addresshttps://doi.org/10.3389/fchem.2020.595273
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.